Health technology assessment in the Irish healthcare setting : application to oral anticoagulants
Citation:
Laura M. McCullagh, 'Health technology assessment in the Irish healthcare setting : application to oral anticoagulants', [thesis], Trinity College (Dublin, Ireland). School of Medicine. Discipline of Pharmacology & Therapeutics, 2012, pp 316Download Item:
Abstract:
The objective of this thesis was to examine the application of economic evaluation within the Irish healthcare setting. In so doing, the author sought to develop skills in indirect comparison, economic modelling, value of information analysis and prescribing database analysis. The therapeutic area chosen was the new oral anticoagulants. Rivaroxaban (Xarelto®) and dabigatran (Pradaxa®) were licensed in Ireland in 2008 for the primary prevention of venous thromboembolism (VTE) in adults undergoing elective total hip replacement (THR) and total knee replacement (TKR).
Author: McCullagh, Laura M.
Advisor:
Barry, MichaelQualification name:
Doctor of Philosophy (Ph.D.)Publisher:
Trinity College (Dublin, Ireland). School of Medicine. Discipline of Pharmacology & TherapeuticsNote:
TARA (Trinity’s Access to Research Archive) has a robust takedown policy. Please contact us if you have any concerns: rssadmin@tcd.ieType of material:
thesisCollections
Availability:
Full text availableMetadata
Show full item recordLicences: